Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02470403 · ClinicalTrials.gov registry record · Phase 2
Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index
A Phase 2 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 181
- Enrollment target
NCT02470403 is a Phase 2 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 181 participants.
The verdict
NCT02470403, a Phase 2 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 181 participants
- Enrollment target
Study Summary
A 12-week study to assess LIK066 effect on body weight in diabetics, prediabetics and normoglycemic patients with elevated body mass index (BMI)
Interventions
- DRUG Placebo
- DRUG LIK066
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2015-06-05 |
| Est. Completion | 2016-04-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02470403
The ClinicalTrials.gov registry entry for NCT02470403 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02470403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02470403 about?
NCT02470403 is a clinical study titled "Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index". A 12-week study to assess LIK066 effect on body weight in diabetics, prediabetics and normoglycemic patients with elevated body mass index (BMI)
What is the current status of trial NCT02470403?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 181 participants. The study started on 2015-06-05. Estimated completion is 2016-04-04.
What interventions are being tested in trial NCT02470403?
The interventions under investigation include: Placebo (DRUG), LIK066 (DRUG).
Who is sponsoring clinical trial NCT02470403?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.